Satoshi Igawa

ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 10

Top Venues

Thoracic cancer

Investigational new drugs

This page only lists publications with an associated author ORCID identifier.

Publications

Ou Yamaguchi, Keita Mori, Saori Takata, Kazuhiko Shibata, Kenichi Chikamori, Nozomu Kimura, Yoshiaki Nagai, Taku Nakagawa, Satoshi Igawa, Taishi Harada, Hiroshige Yoshioka, Hisashi Tanaka, Hitomi Nogawa, Toshihiro Shiozawa, Toshihiro Shiozawa, Kosuke Tsuji, Kunihiko Kobayashi, Kyoichi Kaira
Extended ICI treatment after first-line chemoimmunotherapy could predict the clinical benefit of ramucirumab plus docetaxel in advanced non-small lung cancer: Post hoc analysis from NEJ051 (REACTIVE study). Thoracic cancer (2023)
Satoshi Igawa, Tomoya Fukui, Masashi Kasajima, Taihei Ono, Takahiro Ozawa, Mikiko Kakegawa, Seiichiro Kusuhara, Takashi Sato, Yoshiro Nakahara, Mitsufuji Hisashi, Jiichiro Sasaki, Katsuhiko Naoki
First-line osimertinib for poor performance status patients with EGFR mutation-positive non-small cell lung cancer: A prospective observational study. Investigational new drugs (2021)
Satoshi Igawa, Masanori Yokoba, Akira Takakura, Shinji Hosotani, Yoshiro Nakahara, Takashi Sato, Hisashi Mitsufuji, Jiichiro Sasaki, Katsuhiko Naoki
Real-world evaluation of second line chemotherapy for patients with advanced non-small cell lung cancer harboring preexisting interstitial lung disease. Investigational new drugs (2021)
Seiichiro Kusuhara, Satoshi Igawa, Masaaki Ichinoe, Ryo Nagashio, Yuki Kuchitsu, Yasuhiro Hiyoshi, Kazu Shiomi, Yoshiki Murakumo, Makoto Saegusa, Yukitoshi Satoh, Yuichi Sato, Katsuhiko Naoki
Prognostic significance of galectin-3 expression in patients with resected NSCLC treated with platinum-based adjuvant chemotherapy. Thoracic cancer 12 (10) (2021)
Tomoya Fukui, Shinji Hosotani, Itaru Soda, Takahiro Ozawa, Seiichiro Kusuhara, Mikiko I Kakegawa, Masashi Kasajima, Yasuhiro Hiyoshi, Satoshi Igawa, Masanori Yokoba, Hisashi Mitsufuji, Masaru Kubota, Masato Katagiri, Jiichiro Sasaki, Hiromichi Ishiyama, Katsuhiko Naoki
Current status and progress of concurrent chemoradiotherapy in patients with locally advanced non-small cell lung cancer prior to the approval of durvalumab. Thoracic cancer 11 (4) (2020)
Yasuhiro Hiyoshi, Yuichi Sato, Masaaki Ichinoe, Ryo Nagashio, Daisuke Hagiuda, Makoto Kobayashi, Seiichiro Kusuhara, Satoshi Igawa, Kazu Shiomi, Naoki Goshima, Yoshiki Murakumo, Makoto Saegusa, Yukitoshi Satoh, Noriyuki Masuda, Katsuhiko Naoki
Prognostic significance of IMMT expression in surgically-resected lung adenocarcinoma. Thoracic cancer 10 (11) (2019)
Tomoya Fukui, Mikiko Ishihara, Masashi Kasajima, Yasuhiro Hiyoshi, Yoshiro Nakahara, Sakiko Otani, Satoshi Igawa, Masanori Yokoba, Hisashi Mitsufuji, Masaru Kubota, Masato Katagiri, Jiichiro Sasaki, Katsuhiko Naoki
Questionnaire survey on patient awareness of invasive rebiopsy in advanced non-small cell lung cancer. Thoracic cancer 10 (3) (2019)
Taihei Ono, Satoshi Igawa, Takahiro Ozawa, Masashi Kasajima, Mikiko Ishihara, Yasuhiro Hiyoshi, Seiichiro Kusuhara, Noriko Nishinarita, Tomoya Fukui, Masaru Kubota, Jiichiro Sasaki, Mitsufuji Hisashi, Masato Katagiri, Katsuhiko Naoki
Evaluation of osimertinib efficacy according to body surface area and body mass index in patients with non-small cell lung cancer harboring an EGFR mutation: A prospective observational study. Thoracic cancer 10 (4) (2019)
Satoshi Igawa, Masayuki Shirasawa, Takahiro Ozawa, Noriko Nishinarita, Yuriko Okuma, Taihei Ono, Ai Sugimoto, Shintaro Kurahayashi, Keisuke Sugita, Hideyuki Sone, Tomoya Fukui, Hisashi Mitsufuji, Masaru Kubota, Masato Katagiri, Jiichiro Sasaki, Katsuhiko Naoki
Comparison of carboplatin plus etoposide with amrubicin monotherapy for extensive-disease small cell lung cancer in the elderly and patients with poor performance status. Thoracic cancer 9 (8) (2018)
Hideyuki Sone, Satoshi Igawa, Masashi Kasajima, Mikiko Ishihara, Yasuhiro Hiyoshi, Shinji Hosotani, Shuntaro Ohe, Hiroki Ito, Nobuki Kaizuka, Hiroya Manaka, Tomoya Fukui, Hisashi Mitsufuji, Masaru Kubota, Masato Katagiri, Jiichiro Sasaki, Katsuhiko Naoki
Amrubicin monotherapy for elderly patients with relapsed extensive-disease small-cell lung cancer: A retrospective study. Thoracic cancer 9 (10) (2018)

Satoshi Igawa.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Satoshi Igawa